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13.09.005Abstract Pluripotency-associated factors and their rivals, lineage speciﬁers, have long been consid-
ered the determining factors for the identity of pluripotent and differentiated cells, respectively.
Therefore, factors that are employed for cellular reprogramming in order to induce pluripotency
have been identiﬁed mainly from embryonic stem cell (ESC)-enriched and pluripotency-associated
factors. Recently, lineage speciﬁers have been identiﬁed to play important roles in orchestrating the
process of restoring pluripotency. In this review, we summarize the latest discoveries regarding cell
fate conversion using pluripotency-associated factors and lineage speciﬁers. We highlight the value
of the ‘‘seesaw’’ model in deﬁning cellular identity, opening up a novel scenario to consider pluri-
potency and lineage speciﬁcation.Introduction
Understanding how cellular identity is established is a major
goal for modern biology. The programming and reprogram-
ming of cellular identity elicit tremendous scientiﬁc and public
interest. The groundbreaking work of Takahashi and Yama-
naka established a precedent with the generation of induced
pluripotent stem cells (iPSCs) by the forced expression of only(Deng H).
eijing Institute of Genomics,
tics Society of China.
g by Elsevier
ing Institute of Genomics, Chinese Afour transcription factors –– Oct4, Sox2, Klf4 and c-Myc [1].
Similar to embryonic stem cells (ESCs), iPSCs can proliferate
and self-renew indeﬁnitely under appropriate conditions and
give rise to all types of cells in the body, which bestows these
cells with many potential uses in regenerative medicine. Pa-
tients with degenerative diseases such as diabetes and cancer,
along with aging individuals could all beneﬁt from iPSC-based
therapies [2].
The discovery of iPSCs
Somatic cells can be reprogrammed by nuclear transfer [3] or
by fusion with ESCs [4], suggesting that oocytes and ESCs
contain factors that can reprogram somatic cells into stem
cells. Inspired by this discovery, Yamanaka and his colleagues
selected 24 genes that are speciﬁcally expressed in ESCs, whichcademy of Sciences and Genetics Society of China. Production and hosting
260 Genomics Proteomics Bioinformatics 11 (2013) 259–263also play important roles in the maintenance of ESC identity,
as candidate factors to induce pluripotency in mouse somatic
cells. By transducing all 24 candidate genes together, G418-
resistant colonies were generated by using Fbx15bgeo/bgeo as a
selection marker for pluripotency. These cells were further
identiﬁed to possess ESC properties. To determine which of
the 24 candidates were essential, Yamanaka and his colleagues
tested the effects of the withdrawal of individual factors from
the 24-candidate gene pool on the generation of G418-resistant
colonies. Ultimately Oct4, Sox2, Klf4 and c-Myc were identi-
ﬁed to be pivotal for the induction of pluripotency in mouse
somatic cells [1]. Furthermore, these factors were proven to
be able to induce pluripotency in human somatic cells as well
[5].
Other laboratories have also been working on inducing plu-
ripotency in somatic cells. By using Lin28 and Nanog together
with Oct4 and Sox2, the Thomson laboratory also indepen-
dently discovered a set of four reprogramming factors that
are highly enriched in ESCs [6]. These ﬁrst proof-of-principle
studies opened the realms of iPSC research to a future in
regenerative medicine.
Discovering novel pluripotency regulators for the
induction of pluripotency
It is coherent to test whether there are novel ESC-associated
factors that can regulate iPSC induction. Several reports have
suggested factors that are important for the maintenance of
ESC identity can also facilitate the induction of pluripotency.
For example, Nr5a2, an orphan nuclear receptor that is en-
riched in ESCs, can replace Oct4 in the induction of pluripo-
tency [7]. Esrrb, another orphan nuclear receptor that plays a
pivotal role in the maintenance of pluripotency, can replace
Klf4 and c-Myc [8]. PRDM14 and NFRKB were identiﬁed as
novel determinants of human ESC identity and can substitute
for Klf4 in reprogramming [9]. Recently, by a single-cell anal-
ysis of the reprogramming process, Lin28, Sall4, Esrrb and
Dppa2 were identiﬁed as a completely novel set of reprogram-
ming factors [10], which are different from the factors initially
identiﬁed by Yamanaka et al. These factors are all important
for the maintenance of ESC identity [10]. In addition to the
highly expressed factors in ESCs, the maternal factor Glis1
in oocytes was reported to be a novel facilitator of reprogram-
ming [11].
Direct reprogramming into iPSCs by lineage
speciﬁers
For years, it was generally believed that ESCs are maintained
by a shield of pluripotency factors. These factors function in
concert with each other to prevent ESCs from differentiating
into any lineage, thus preserving the ESCs at an undifferenti-
ated state [12,13]. A more challenging perspective has been
put forward recently. Pluripotency factors might as well func-
tion as classical lineage speciﬁers that direct ESCs to differen-
tiate into a speciﬁc lineage and inhibit their commitment to
mutually exclusive lineages [14].
Consistent with the notion, in ESCs, Oct4 promotes the
differentiation of mesendoderm (ME) and primitive endoderm,
while suppressing differentiation of the ectoderm (ECT)[15–17]; Sox2 inhibits ME differentiation but promotes neural
ECT differentiation [16,17]. Shu et al. provided the ﬁrst proof-
of-principle report showing that modulating lineage-specifying
forces can restore the pluripotency of mouse somatic cells [18].
When screening for factors that may substitute for Oct4 in
the induction of pluripotency, Shu et al. found that GATA3,
which is known to regulate ME commitment and speciﬁcation,
can substitute for Oct4. Subsequent analysis of other lineage
speciﬁers that mainly function in ME differentiation and early
embryonic patterning, which are generally not enriched in
ESCs, found that GATA6, SOX7 and PAX1, among others,
were also able to substitute for Oct4 to induce pluripotency,
whereas ectodermal speciﬁers could not. All Oct4 substitutes
were also able to attenuate the upregulated expression of
ECT-associated genes that is triggered by the expression of
Sox2, Klf4 and c-Myc (SKM), whereas knockdown of the
key ectodermal marker Dlx3 promoted SKM-only reprogram-
ming [18]. These ﬁndings suggest that a novel function of Oct4/
GATA3 is to suppress ECT differentiation during
reprogramming.
Accordingly, the ECT lineage speciﬁers SOX1, SOX3,
RCOR2 and GMNN can replace Sox2 during reprogramming.
Similarly, Sox2 and its substitutes attenuate the expression of
ME-speciﬁc markers induced by expression of Oct4, Klf4 and
c-Myc (OKM) [18–20]. Strikingly, co-expression of GATA6
and GMNN can substitute for Oct4 and Sox2 to reprogram
mouse ﬁbroblasts into iPSCs in the presence of Klf4 and c-
Myc [18].
More recently, Montserrat et al. showed that lineage speci-
ﬁers can also be used to reprogram human ﬁbroblasts into iPS-
Cs. The authors found that GATA3 can replace OCT4 and the
ECT speciﬁer, ZNF521, can replace SOX2. Lastly, they
showed that GATA3, together with ZNF521, OTX2 and
PAX6, can substitute for both OCT4 and SOX2 for human
iPSC induction in the presence of KLF4 and c-MYC [21].
A ‘‘seesaw’’ model for cell fate conversion
A binodal model for cell fate determination, such as GATA1
and PU.1, RUNX2 and PPARc, has been examined in various
instances of pluripotent stem or progenitor cells that assume a
binary cell fate decision [22]. Such circuit hints at the concept
of a ‘‘balanced pluripotent state’’. Inspired by these insights,
Shu et al. proposed a new model, termed the ‘‘seesaw’’ model,
in which the pluripotent state has a precarious balancing equi-
librium that results from continuous mutual competition be-
tween rival lineage speciﬁcation forces (Figure 1). This model
comprises two coupled modules–– the canonical pluripotency
module and the lineage-antagonism module. The former mod-
ule is represented by the mutual activation of Oct4 and Sox2,
whereas mutual inhibition of the ME and ECT genes repre-
sents the latter module [18].
Both the canonical pluripotency module and the lineage-
antagonism module are incorporated leading into the integrated
‘‘seesaw’’ model. The novelty of the ‘‘seesaw’’model is the proper
combination of the two modules. This model led to unexpected
insights and scenarios of cell fate conversion. The activation of
the cross-activating pluripotency module is important for the
reestablishment of the pluripotency network to achieve successful
reprogramming. The self-activating pluripotency module gets
activated when all of the lineage-specifying forces are
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Figure 1 A ‘‘seesaw’’ model for cell fate conversion
A modiﬁed diagram of the ‘‘seesaw’’ model [18]. Blue clouds indicate the regions that the cell states are likely to sample with noise. The
pluripotent state (red ball) is located near the balance region. When the seesaw is balanced between the two differentiation potentials, the
cell has a higher probability of entering the pluripotent state. ME stands for mesendoderm and ECT stands for ectoderm.
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other words, no particular lineage-specifying activity is dominant
in inhibiting the pluripotency module. In this case, the pluripo-
tent state becomes achievable, eliciting the Oct4 and Sox2 self-
activating module to coordinate with other pluripotency factors,
thus collaboratively restoring the pluripotency network. Once
the cross-activating pluripotency module is activated, the ME
and ECT lineage fates are blocked by Sox2 and Oct4, respec-
tively. As a result, the pluripotent state is maintained [18].
This innovative model can illustrate the aforementioned
points and predicts novel strategies for cell fate conversion,
including strategies for the direct conversion of somatic cells
into iPSCs by pluripotency factors or lineage speciﬁers along
with the direct conversion of somatic cells into speciﬁc lineages
by lineage speciﬁers or pluripotency factors.Direct reprogramming into other cell types by
lineage speciﬁers or pluripotency factors
The direct reprogramming strategy for cell fate conversion has
beenwidely adapted for some other cell types in addition to iPSCs.
The direct conversion of ﬁbroblasts into myoblasts by over-
expressing MyoD was reported in 1987 by Davis and colleagues
[23]. Recently, increasing numbers of different cell types have been
obtained by direct conversion, termed transdifferentiation. For
example, a combination of three neuronal lineage-speciﬁc tran-
scription factors, Ascl1, Brn2 and Mytl1, is sufﬁcient to induce
neurons from ﬁbroblasts [24]. The cardiac-speciﬁc transcription
factors Gata4, Tbx5 andMef2c can induce ﬁbroblast transdiffer-
entiation into cardiomyocytes [25]. It is therefore assumed that
the more speciﬁc and closer the endogenous regulatory network
is to the factors, the more efﬁcient the conversion will be [26].The ‘‘seesaw’’ model also predicts that inhibiting the mu-
tual antagonistic lineage-specifying forces could convert one
cell type into another.
Furthermore, consistent with the ‘‘seesaw’’ model, repro-
gramming factors have been reported to directly produce line-
age-committed cells. Two pivotal pluripotency factors, Oct4
and Sox2, were reported to regulate ESC differentiation into
different germ layers and to induce direct conversions between
different cell types beyond iPSCs.
Previous studies have shown that a twofold increase in Oct4
expression induces ESCs toward mesendodermal speciﬁcation
[15], whereas high levels of Sox2 trigger the neuroectodermal
commitment of ESCs. Recently, it was reported that Oct4
and Sox2 also orchestrate a germ-layer fate selection. Oct4
inhibits neuroectodermal differentiation and promotes mesen-
dodermal differentiation, whereas Sox2 promotes neuroecto-
dermal differentiation and inhibits mesendodermal
differentiation [16,17].
More recently, overexpression of Oct4 in ﬁbroblasts was
shown to lead to transdifferentiation into hematopoietic cells
of a mesendodermal lineage [27], whereas overexpression of
Sox2 directly converted ﬁbroblasts into neural stem cells.
Additionally, decreased expression of Oct4 among the four
Yamanaka factors can result in the direct conversion of ﬁbro-
blasts into neural stem cells [28–30]. These discoveries suggest
that pluripotency factors, such as Oct4 and Sox2, can regulate
not only pluripotency but also lineage speciﬁcation.Conclusion and outlook
After the discovery of the famous Yamanaka factors, a set of
transcription factors consisting of Oct4, Sox2, Klf4 and
262 Genomics Proteomics Bioinformatics 11 (2013) 259–263c-Myc, regenerative biology has stepped into a new era.
Increasing numbers of pluripotency-related factors have been
identiﬁed either to replace the Yamanaka factors or to boost
the process. Meanwhile, direct transdifferentiation has been
successfully demonstrated through a similar strategy, by
using lineage-speciﬁc transcription factors for specifying each
lineage fate. Recently, discoveries and notions related to the
‘‘seesaw’’ model for cell fate conversion have introduced a
novel scenario for cell fate conversion causing us to
re-evaluate the characteristics of pluripotency factors and
lineage speciﬁers, which are two rivals in the conventional
conception of the development of cellular identity. Increasing
evidence suggests that pluripotency factors are also lineage
speciﬁers. For example, Oct4 speciﬁes ME differentiation
while inhibiting ECT differentiation, and induces hematopoi-
etic transdifferentiation from ﬁbroblasts. Sox2 directs ECT
differentiation while prohibiting ME commitment, and in-
duces direct transdifferentiation from ﬁbroblasts into neural
stem cells. Overexpression of Nanog, Esrrb, or Tbx3 pro-
motes mesendodermal determination [14]. Lastly, the lineage
speciﬁers depicted as pluripotency rivals, such as GATA3
and PAX6, have been identiﬁed to be able to restore pluripo-
tency in somatic cells.
Based on these discoveries, we should reconsider the deﬁni-
tions of pluripotency and lineage speciﬁcation and present a
novel perspective for understanding the determinants of cellu-
lar identity, which is one of the most important topics in mod-
ern biology.
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